文献速递脑血管病

2006至2017年第戎卒中登记中房颤相关缺血性卒中的特征与时间趋势

Ischemic Stroke With Atrial Fibrillation: Characteristics and Time Trends 2006 to 2017 in the Dijon Stroke Registry.
PubMed 文献 · Stroke · 2021-04-20

基于法国第戎卒中登记的人群研究,纳入2006至2017年所有缺血性卒中患者,分析房颤患病率、特征及时间趋势。2014至2017年796例缺血性卒中患者中30.0%有房颤,其中9.9%为新诊断房颤;房颤患者残疾更重、初始严重度更高。年龄调整后房颤患病率随时间上升,口服抗凝治疗使用增加但仍有未充分治疗。

要点

  • 2014至2017年第戎登记中30.0%的缺血性卒中患者合并房颤。
  • 房颤相关缺血性卒中患者残疾和初始神经功能缺损更严重。
  • 既往房颤患者口服抗凝使用从29.3%升至61.3%,但仍存在未充分治疗。

核心结论

  • 缺血性卒中患者中房颤患病率增加可能与诊断改善有关,口服抗凝治疗不足仍然存在。

研究设计与样本

  • 基于第戎卒中登记的人群研究,纳入2006至2017年所有缺血性卒中患者。
  • 2014至2017年共记录796例缺血性卒中患者。

主要发现

  • 2014至2017年796例缺血性卒中患者中239例(30.0%)有房颤,其中79例(占全部缺血性卒中9.9%)为新诊断房颤。
  • 98例(12.3%)为既往房颤且接受口服抗凝治疗。
  • 房颤相关缺血性卒中患者相比无房颤者残疾更多、美国国立卫生研究院卒中量表初始严重度更高。
  • 2006至2017年缺血性卒中患者中年龄调整房颤患病率每时间段增加9%,65至74岁男性增加81%,≥85岁女性增加24%,65至74岁女性减少39%。
  • 既往房颤患者口服抗凝治疗使用从2006至2009年的29.3%增至2014至2017年的61.3%(P<0.0001)。

关键数值与推荐

  • 既往房颤定义为卒中前医疗记录中提及房颤,新诊断房颤定义为急性卒中诊断检查期间诊断。
  • 37.5%的既往房颤且CHADS2评分≥2的患者未接受口服抗凝治疗。

临床怎么用

  • 临床应关注缺血性卒中患者中房颤的筛查与诊断。
  • 对既往房颤且CHADS2评分≥2的卒中患者应评估口服抗凝治疗是否充分。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND AND PURPOSE: Because of the aging population, an increase in the prevalence of atrial fibrillation (AF) is currently observed, thus leading to a rise in AF-related ischemic stroke (IS). We analyzed the current prevalence of AF among patients with IS, their characteristics, and temporal trends from 2006 to 2017 in the population-based Dijon Stroke Registry. METHODS: We used data from the Dijon Stroke Registry, an ongoing population-based study that records all cases of acute stroke among residents of the city of Dijon. All patients with IS between 2006 and 2017 were included. Previous AF was defined if it was mentioned in the medical file before stroke and newly diagnosed AF if it was diagnosed during the diagnostic workup of patients with acute stroke. RESULTS: During the period 2014 to 2017, among the 796 patients with IS recorded in the Dijon Stroke Registry, 239 (30.0%) had AF, of whom 79 (9.9% of total patients with IS) had newly diagnosed AF, and 98 (12.3%) had previous AF treated with oral anticoagulants. Patients with IS with AF had more disabilities and a higher initial severity according to the National Institutes of Health Stroke Scale compared with those without AF. The age-adjusted prevalence of AF in patients with IS increased between 2006 and 2017 (+9% per time period), with an important increase in men aged 65 to 74 years (+81%) and women aged ≥85 years (+24%), and a significant decrease in women aged 65 to 74 years (−39%). The use of oral anticoagulant treatment in previous AF patients increased between 2006 and 2009 and 2014 and 2017 (29.3% to 61.3%, P<0.0001). However, 37.5% of patients with previous AF and CHADS2 score ≥2 were not treated with OAC. CONCLUSIONS: The increase in AF prevalence in patients with IS could be related to a better diagnosis of this condition. The underuse of oral anticoagulation treatment was still observed.

来源:Stroke,查看原文。版权归原作者所有。

引用

  1. Gabet A, Guenancia C, Duloquin G, et al. Ischemic Stroke With Atrial Fibrillation: Characteristics and Time Trends 2006 to 2017 in the Dijon Stroke Registry. Stroke. 2021. PMID: 33874745. doi:10.1161/STROKEAHA.120.030812

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。